Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Lung emphysema and impaired macrophage elastase clearance in mucolipin 3 deficient mice

  • Barbara Spix
  • , Elisabeth S. Butz
  • , Cheng-Chang Chen
  • , Anna Scotto Rosato
  • , Rachel Tang
  • , Aicha Jeridi
  • , Veronika Kudrina
  • , Eva Plesch
  • , Philipp Wartenberg
  • , Elisabeth Arlt
  • , Daria Briukhovetska
  • , Meshal Ansari
  • , Gizem Günes Günsel
  • , Thomas M. Conlon
  • , Amanda Wyatt
  • , Sandra Wetzel
  • , Daniel Teupser
  • , Lesca M. Holdt
  • , Fabien Ectors
  • , Ingrid Boekhoff
  • Ulrich Boehm, Jaime García-Añoveros, Paul Saftig, Martin Giera, Sebastian Kobold, Herbert B. Schiller, Susanna Zierler, Thomas Gudermann, Christian Wahl-Schott, Franz Bracher, Ali Önder Yildirim, Martin Biel, Christian Grimm

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Abstract

Lung emphysema and chronic bronchitis are the two most common causes of chronic obstructive pulmonary disease. Excess macrophage elastase MMP-12, which is predominantly secreted from alveolar macrophages, is known to mediate the development of lung injury and emphysema. Here, we discovered the endolysosomal cation channel mucolipin 3 (TRPML3) as a regulator of MMP-12 reuptake from broncho-alveolar fluid, driving in two independently generated Trpml3−/− mouse models enlarged lung injury, which is further exacerbated after elastase or tobacco smoke treatment. Mechanistically, using a Trpml3IRES-Cre/eR26-τGFP reporter mouse model, transcriptomics, and endolysosomal patch-clamp experiments, we show that in the lung TRPML3 is almost exclusively expressed in alveolar macrophages, where its loss leads to defects in early endosomal trafficking and endocytosis of MMP-12. Our findings suggest that TRPML3 represents a key regulator of MMP-12 clearance by alveolar macrophages and may serve as therapeutic target for emphysema and chronic obstructive pulmonary disease.
OriginalspracheEnglisch
Aufsatznummer318
Seitenumfang18
Fachzeitschriftnature communications
Volume13
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - 14 Jän. 2022

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gute Gesundheit und Wohlergehen
    SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

  • 301206 Pharmakologie

Dieses zitieren